Literature DB >> 14577022

The effects of corticosteroids on behavior in children with nephrotic syndrome.

A S Hall1, G Thorley, P N Houtman.   

Abstract

The objective of this study was to measure the frequency and severity of the behavioral effects of high-dose oral steroid therapy in children with nephrotic syndrome. We conducted a prospective assessment of the behavior of 12 children using a standardized psychological questionnaire at the time of diagnosis and again after 4 weeks of steroid therapy. A group of control children was also assessed. There was a significant increase in the total behavior score ( P=0.03) and specifically in aggressive and poor attention behavior items in the group of nephrotic children compared with the control group. Four of the children with nephrotic syndrome developed abnormal behavior in the clinical range compared with none of the controls. In conclusion, children with nephrotic syndrome treated with high-dose oral steroids are at risk of developing clinically relevant behavioral changes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14577022     DOI: 10.1007/s00467-003-1295-x

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  14 in total

1.  Psychic and somatic changes observed in allergic children after prolonged steroid therapy.

Authors:  G ESTRADA DE LA RIVA
Journal:  South Med J       Date:  1958-07       Impact factor: 0.954

2.  Association between corticosteroids and psychologic change in hospitalized asthmatic children.

Authors:  B G Bender; J A Lerner; J E Poland
Journal:  Ann Allergy       Date:  1991-05

3.  Behavioral effects of corticosteroids in children with acute lymphoblastic leukemia.

Authors:  R Drigan; A Spirito; R D Gelber
Journal:  Med Pediatr Oncol       Date:  1992

4.  Mood and memory changes in asthmatic children receiving corticosteroids.

Authors:  B G Bender; J A Lerner; E Kollasch
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1988-11       Impact factor: 8.829

Review 5.  The acute effects of corticosteroids on cognition: integration of animal and human model studies.

Authors:  S J Lupien; B S McEwen
Journal:  Brain Res Brain Res Rev       Date:  1997-06

Review 6.  Mood symptoms during corticosteroid therapy: a review.

Authors:  E S Brown; T Suppes
Journal:  Harv Rev Psychiatry       Date:  1998 Jan-Feb       Impact factor: 3.732

7.  Nephrotic syndrome: from toddlers to twenties.

Authors:  M A Lewis; E M Baildom; N Davis; I B Houston; R J Postlethwaite
Journal:  Lancet       Date:  1989-02-04       Impact factor: 79.321

8.  Cognitive sequelae in children treated for acute lymphoblastic leukemia with dexamethasone or prednisone.

Authors:  D P Waber; S C Carpentieri; N Klar; L B Silverman; M Schwenn; C A Hurwitz; P J Mullenix; N J Tarbell; S E Sallan
Journal:  J Pediatr Hematol Oncol       Date:  2000 May-Jun       Impact factor: 1.289

9.  Corticosteroid therapy in nephrotic syndrome: a meta-analysis of randomised controlled trials.

Authors:  E M Hodson; J F Knight; N S Willis; J C Craig
Journal:  Arch Dis Child       Date:  2000-07       Impact factor: 3.791

10.  High incidence of minimal change nephrotic syndrome in Asians.

Authors:  J Feehally; N P Kendell; P G Swift; J Walls
Journal:  Arch Dis Child       Date:  1985-11       Impact factor: 3.791

View more
  20 in total

1.  Steroid-induced alterations of mood and behavior in children during treatment for acute lymphoblastic leukemia.

Authors:  Carl J Hochhauser; Michael Lewis; Barton A Kamen; Peter D Cole
Journal:  Support Care Cancer       Date:  2005-09-28       Impact factor: 3.603

2.  Inflammatory bowel disease in children: psychological and psychiatric issues.

Authors:  Parikshit Deshmukh; Gaurav Kulkarni; Jeanne Lackamp
Journal:  Curr Psychiatry Rep       Date:  2010-06       Impact factor: 5.285

3.  Preliminary Research on Syndrome Types of Chinese Medicine in Children with Primary Nephrotic Syndrome.

Authors:  Wen Sun; Jian Yu; Gu-Lan Zeng; Bing-Feng Zhang
Journal:  Chin J Integr Med       Date:  2017-08-17       Impact factor: 1.978

4.  Efficacy of higher-dose levamisole in maintaining remission in steroid-dependant nephrotic syndrome.

Authors:  Asiri S Abeyagunawardena; Umeshi Karunadasa; Heshan Jayaweera; Shenal Thalgahagoda; Sampath Tennakoon; Shamali Abeyagunawardena
Journal:  Pediatr Nephrol       Date:  2017-03-15       Impact factor: 3.714

5.  Psychosocial and emotional adjustment for children with pediatric cancer and their primary caregivers and the impact on their health-related quality of life during the first 6 months.

Authors:  Ming-Horng Tsai; Jen-Fu Hsu; Wen-Jiun Chou; Chao-Ping Yang; Tang-Her Jaing; Iou-Jih Hung; Hwey-Fang Liang; Hsuan-Rong Huang; Yu-Shu Huang
Journal:  Qual Life Res       Date:  2012-04-22       Impact factor: 4.147

6.  Use of a low-dose prednisolone regimen to treat a relapse of steroid-sensitive nephrotic syndrome in children.

Authors:  Karnika Raja; Ami Parikh; Hazel Webb; Daljit Hothi
Journal:  Pediatr Nephrol       Date:  2016-09-27       Impact factor: 3.714

7.  Behavioural abnormalities in children with new-onset nephrotic syndrome receiving corticosteroid therapy: results of a prospective longitudinal study.

Authors:  Aishvarya Upadhyay; Om P Mishra; Rajniti Prasad; Shashi K Upadhyay; Franz Schaefer
Journal:  Pediatr Nephrol       Date:  2015-09-28       Impact factor: 3.714

8.  Cases of Psychiatric Morbidity in Pediatric Patients After Remission of Cushing Syndrome.

Authors:  Margaret F Keil; Alan Zametkin; Celia Ryder; Maya Lodish; Constantine A Stratakis
Journal:  Pediatrics       Date:  2016-03-29       Impact factor: 7.124

9.  Impact of rituximab on height and weight in children with refractory steroid-dependent nephrotic syndrome.

Authors:  Mai Sato; Shuichi Ito; Masao Ogura; Koichi Kamei
Journal:  Pediatr Nephrol       Date:  2014-03-07       Impact factor: 3.714

10.  Psychosocial and cognitive function in children with nephrotic syndrome: association with disease and treatment variables.

Authors:  Maria Alexandra Magiakou; Gerasimos Kolaitis; Panagiota Manti; George Giannakopoulos; Elena Giouroukou; Helen Georgaki-Angelaki; Constantinos J Stefanidis; Andromahi Mitsioni; Nikolaos Stergiou; Constantinos Mihas; George P Chrousos
Journal:  Biopsychosoc Med       Date:  2013-04-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.